TriSalus Life Sciences Warrant
TLSIW
30 hedge funds and large institutions have $7.54M invested in TriSalus Life Sciences Warrant in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
15% more funds holding
Funds holding: 26 → 30 (+4)
6% less capital invested
Capital invested by funds: $8.05M → $7.54M (-$505K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$46.3K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$21.9K |
| 3 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
+$12.7K |
| 4 |
CM
CastleKnight Management
New York
|
+$8.87K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
-$13K |
| 2 |
MA
MYDA Advisors
Woodmere,
New York
|
-$11K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$3.09K |
| 4 |
Jane Street
New York
|
-$40 |
TLSIW Hedge Fund Activity: Q2 2022 in Review
30 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q2 2022, worth a combined $7.54M — down 6.3% from $8.05M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TLSIW positions and 3 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Clear Street, opening a new position worth an estimated $46.3K. The largest seller was Q Global Advisors, exiting entirely with an estimated $13K sold.
- 30 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q2 2022, up from 26 in Q1 2022.
- Funds reported $7.54M of TriSalus Life Sciences Warrant stock for Q2 2022, down 6.3% quarter-over-quarter.
- 7 funds opened new TriSalus Life Sciences Warrant positions in Q2 2022 and 3 closed out, a net change of +4 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q2 2022 was Clear Street, an estimated $46.3K added.
- The largest TriSalus Life Sciences Warrant seller in Q2 2022 was Q Global Advisors, an estimated $13K sold.
Based on aggregated 13F filings for Q2 2022.